Market Place
Sourcing Support
All News #Library
Biotech
Galecto Announces Name Change to Damora Therapeutics
09 Mar 2026 //
GLOBENEWSWIRE
Galecto To Join Leerink Partners Global Healthcare Conference
02 Mar 2026 //
GLOBENEWSWIRE
Galecto Emphasizes Strategic Goals And 2026 Milestones
12 Jan 2026 //
GLOBENEWSWIRE
Galecto Announces Key Additions To Leadership Team
06 Jan 2026 //
GLOBENEWSWIRE
Galecto Reports Q3 2025 Operating And Financial Results
06 Nov 2025 //
GLOBENEWSWIRE
Galecto To Highlight GB3226 Program at ASH 2025
03 Nov 2025 //
GLOBENEWSWIRE
Galecto Reports Q2 2025 Operating and Financial Performance
05 Aug 2025 //
GLOBENEWSWIRE
Galecto Reports Q1 2025 Results
08 May 2025 //
GLOBENEWSWIRE
Galecto to Participate in Upcoming Investor Conferences
06 Feb 2025 //
GLOBENEWSWIRE
Galecto Reports Q3 2024 Financial Results
01 Nov 2024 //
GLOBENEWSWIRE
Galecto Strengthens Board of Directors with Appointment of Dr. Amy
15 Oct 2024 //
GLOBENEWSWIRE
Galecto buys leukemia drug, drops bone cancer asset in pivot
08 Oct 2024 //
FIERCE BIOTECH
Galecto Announces Reverse Stock Split
28 Aug 2024 //
GLOBENEWSWIRE
Galecto: First Patient Dosed In GB1211-Pembrolizumab Combo Trial
01 May 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.